Evidence map›Paper›PMID 25120361›Full record

ArticleInternational journal of nanomedicine2014

Effects of size and surface of zinc oxide and aluminum-doped zinc oxide nanoparticles on cell viability inferred by proteomic analyses.

Chih-Hong Pan, Wen-Te Liu, Mauo-Ying Bien, I-Chan Lin, Ta-Chih Hsiao, Chih-Ming Ma, Ching-Huang Lai, Mei-Chieh Chen, Kai-Jen Chuang, Hsiao-Chi Chuang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chih-Hong PanInstitute of Labor, Occupational Safety and Health, Ministry of Labor, Taipei Medical University Hospital, Taipei, Taiwan ; School of Public Health, National Defense Medical Center, Taipei Medical University Hospital, Taipei, Taiwan.
Wen-Te LiuDivision of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University Hospital, Taipei, Taiwan ; School of Respiratory Therapy, College of Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Mauo-Ying BienSchool of Respiratory Therapy, College of Medicine, Taipei Medical University Hospital, Taipei, Taiwan ; Division of Pulmonary Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
I-Chan LinDepartment of Ophthalmology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
Ta-Chih HsiaoGraduate Institute of Environmental Engineering, National Central University, Taoyuan, Taiwan.
Chih-Ming MaDepartment of Cosmetic Application and Management, St Mary's Junior College of Medicine, Nursing and Management, Sanxing, Taiwan.
Ching-Huang LaiSchool of Public Health, National Defense Medical Center, Taipei Medical University Hospital, Taipei, Taiwan.
Mei-Chieh ChenDepartment of Microbiology and Immunology, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Kai-Jen ChuangDepartment of Public Health, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan ; School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.
Hsiao-Chi ChuangDivision of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University Hospital, Taipei, Taiwan ; School of Respiratory Therapy, College of Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
Taipei Medical University · TWNational Central University · TWTaipei Medical University-Shuang Ho Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the health effects of zinc oxide nanoparticles (ZnONPs) on the respiratory system have been reported, the fate, potential toxicity, and mechanisms in biological cells of these particles, as related to particle size and surface characteristics, have not been well elucidated. To determine the physicochemical properties of ZnONPs that govern cytotoxicity, we investigated the effects of size, electronic properties, zinc concentration, and pH on cell viability using human alveolar-basal epithelial A549 cells as a model. We observed that a 2-hour or longer exposure to ZnONPs induced changes in cell viability. The alteration in cell viability was associated with the zeta potentials and pH values of the ZnONPs. Proteomic profiling of A549 exposed to ZnONPs for 2 and 4 hours was used to determine the biological mechanisms of ZnONP toxicity. p53-pathway activation was the core mechanism regulating cell viability in response to particle size. Activation of the Wnt and TGFβ signaling pathways was also important in the cellular response to ZnONPs of different sizes. The cadherin and Wnt signaling pathways were important cellular mechanisms triggered by surface differences. These results suggested that the size and surface characteristics of ZnONPs might play an important role in their observed cytotoxicity. This approach facilitates the design of more comprehensive systems for the evaluation of nanoparticles.

Indexed as

Aluminum OxideMetal NanoparticlesZinc OxideCell LineCell SurvivalHumansProteinsProteomeAluminum OxideProteinsProteomeZinc Oxidealuminium-doped zinc oxidenanoparticlepHtoxicologyWNT pathwayzeta potential

Identifiers

PMID25120361
PMCPMC4128792
OpenAlexW2037327109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.